Thierry Bussière

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Jeff Sevigny, Ping Chiao, Thierry Bussière et al. · Nature · 2016 · 3.1K citations

Life Sciences, Neurology, Neuroscience +14

Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease

Pantéleimon Giannakopoulos, François R. Herrmann, Thierry Bussière et al. · Neurology · 2003 · 1.1K citations · Full text

Medicine, Neurology, Neuroscience +17

Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β

Joseph W. Arndt, Fang Qian, Benjamin Smith et al. · Scientific Reports · 2018 · 371 citations · Full text

Pharmacy, Biochemistry, Pharmacology +17

Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins—a role in nuclear localization

Tony Lefebvre, Stéphanie Ferreira, L. Dupont-Wallois et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2003 · 201 citations

Life Sciences, Biochemistry, Molecular Biology +14

Kinetic fingerprints differentiate the mechanisms of action of anti-Aβ antibodies

Sara Linse, Tom Scheidt, Katja Bernfur et al. · Nature Structural & Molecular Biology · 2020 · 197 citations

Life Sciences, Biochemistry, Immunology +13